Αρχειοθήκη ιστολογίου
-
▼
2023
(269)
-
▼
Φεβρουαρίου
(133)
-
▼
Φεβ 19
(20)
- Antitumor therapy for breast cancer: Focus on tumo...
- Biomechanical influence of narrow‐diameter implant...
- Equity in adjuvant radiotherapy utilization in loc...
- An evaluation of mechanical and biophysical skin p...
- Multifunctional Two-Dimensional Bi2Se3 Nanodiscs f...
- Downregulation of miR‐193a/b‐3p during HPV‐induced...
- Assessment of attenuation of varicella‐zoster viru...
- Pustular psoriasis in Malaysia: A review of the Ma...
- The prevalence and influencing factors of gag refl...
- The ability of magnetic resonance imaging to predi...
- Risk and incidence of breast cancer in transgender...
- Characterization of Hyaluronan Localization in the...
- LRRK2 Quantification in Cerebrospinal Fluid of Pat...
- Opening of mitochondrial permeability transition p...
- Frequent EGFR exon 20 insertion in the so‐called p...
- Central odontogenic fibroma with amyloid: a diagno...
- Tixagevimab/Cilgavimab Treatment and Cardiovascula...
- The Ixodes ricinus salivary gland proteome during ...
- Characterization of protein-based risk signature t...
- Acute Posterior Multifocal Placoid Pigment Epithel...
-
▼
Φεβ 19
(20)
- ► Ιανουαρίου (136)
-
▼
Φεβρουαρίου
(133)
-
►
2022
(2046)
- ► Δεκεμβρίου (165)
- ► Σεπτεμβρίου (161)
- ► Φεβρουαρίου (165)
-
►
2021
(3028)
- ► Δεκεμβρίου (135)
- ► Σεπτεμβρίου (182)
- ► Φεβρουαρίου (324)
-
►
2020
(1051)
- ► Δεκεμβρίου (292)
- ► Σεπτεμβρίου (60)
- ► Φεβρουαρίου (28)
-
►
2019
(2277)
- ► Δεκεμβρίου (18)
- ► Σεπτεμβρίου (54)
- ► Φεβρουαρίου (89)
-
►
2018
(26280)
- ► Δεκεμβρίου (189)
- ► Φεβρουαρίου (6130)
- ► Ιανουαρίου (7050)
-
►
2017
(33948)
- ► Δεκεμβρίου (6715)
- ► Σεπτεμβρίου (6470)
-
►
2016
(4179)
- ► Σεπτεμβρίου (638)
- ► Φεβρουαρίου (526)
- ► Ιανουαρίου (517)
Τετάρτη 6 Σεπτεμβρίου 2017
An Essential Role of Maspin in Embryogenesis and Tumor Suppression—Response
from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2w8WJma
An Essential Role of Maspin in Embryogenesis and Tumor Suppression—Letter
from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2wIbPTh
Basal-A Triple Negative Breast Cancer Cells Selectively Rely on RNA Splicing for Survival
Prognosis of triple-negative breast cancer (TNBC) remains poor. To identify shared and selective vulnerabilities of basal-like TNBC, the most common TNBC subtype, a directed siRNA lethality screen was performed in 7 human breast cancer cell lines, focusing on 154 previously identified dependency genes of one TNBC line. Thirty common dependency genes were identified, including multiple proteasome and RNA splicing genes, especially those associated with the U4/U6.U5 tri-snRNP complex (e.g., PRPF8, PRPF38A). PRPF8 or PRPF38A knockdown or the splicing modulator E7107 led to widespread intronic retention and altered splicing of transcripts involved in multiple basal-like TNBC dependencies, including protein homeostasis, mitosis and apoptosis. E7107 treatment suppressed the growth of basal-A TNBC cell line and patient-derived basal-like TNBC xenografts at a well-tolerated dose. The anti-tumor response was enhanced by adding the proteasome inhibitor bortezomib. Thus, inhibiting both splicing and the proteasome might be an effective approach for treating basal-like TNBC.
from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2w91n3G
Death by HDAC inhibition in synovial sarcoma cells
Conventional cytotoxic therapies for synovial sarcoma provide limited benefit, and no drugs specifically targeting the causative SS18-SSX fusion oncoprotein are currently available. Histone deacetylase (HDAC) inhibition has been shown in previous studies to disrupt the synovial sarcoma oncoprotein complex, resulting in apoptosis. To understand the molecular effects of HDAC inhibition, RNA-Seq transcriptome analysis was undertaken in six human synovial sarcoma cell lines. HDAC inhibition induced pathways of cell cycle arrest, neuronal differentiation and response to oxygen-containing species, effects also observed in other cancers treated with this class of drugs. More specific to synovial sarcoma, polycomb-group targets were reactivated including tumor suppressor CDKN2A, and pro-apoptotic transcriptional patterns were induced. Functional analyses revealed that ROS-mediated FOXO activation and pro-apoptotic factors BIK, BIM and BMF were important to apoptosis induction following HDAC-inhibition in synovial sarcoma. HDAC-inhibitor pathway activation results in apoptosis and decreased tumor burden following a 7-day quisinostat treatment in the Ptenfl/fl;hSS2 mouse model of synovial sarcoma. This study provides mechanistic support for a particular susceptibility of synovial sarcoma to HDAC inhibition as a means of clinical treatment.
from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2wI1oPw
Interleukin 4 receptor-targeted pro-apoptotic peptide blocks tumor growth and metastasis by enhancing anti-tumor immunity
Cellular crosstalk between tumors and M2-polarized tumor-associated macrophages (TAMs) favors tumor progression. Upregulation of interleukin 4 receptor (IL4R) is observed in diverse tumors and TAMs. We tested whether an IL4R-targeted pro-apoptotic peptide could inhibit tumor progression. The IL4R-binding peptide (IL4RPep-1) preferentially bound to IL4R-expressing tumor cells and M2-polarized macrophages both in vitro and in 4T1 breast tumors in vivo. To selectively kill IL4R-expressing cells, we designed an IL4R-targeted pro-apoptotic peptide, IL4RPep-1-K, by adding the pro-apoptotic peptide (KLAKLAK)2 to the end of IL4RPep-1. IL4RPep-1-K exerted selective cytotoxicity against diverse IL4R-expressing tumor cells and M2-polarized macrophages. Systemic administration of IL4RPep-1-K inhibited tumor growth and metastasis in 4T1 breast tumor-bearing mice. Interestingly, IL4RPep-1-K treatment increased the number of activated cytotoxic CD8+ T cells while reducing the numbers of immunosuppressive regulatory T cells and M2-polarized TAMs. No significant systemic side effects were observed. These results suggest that IL4R-targeted pro-apoptotic peptide has potential for treating diverse IL4R-expressing cancers.
from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2w95rAP
The p97 inhibitor CB-5083 is a unique disrupter of protein homeostasis in models of Multiple Myeloma.
Inhibition of the AAA ATPase, p97, was recently shown to be a novel method for targeting the ubiquitin proteasome system (UPS) and CB-5083, a first in class inhibitor of p97, has demonstrated broad antitumor activity in a range of both hematological and solid tumor models. Here, we show that CB-5083 has robust activity against multiple myeloma (MM) cell lines and a number of in vivo MM models. Treatment with CB-5083 is associated with accumulation of ubiquitinated proteins, induction of the unfolded protein response (UPR) and apoptosis. CB-5083 decreases viability in MM cell lines and patient derived MM cells, including those with background proteasome inhibitor (PI) resistance. CB-5083 has a unique mechanism of action that combines well with PIs which is likely owing to the p97-dependent retro-translocation of the transcription factor, Nrf1, which transcribes proteasome subunit genes following exposure to a PI. In vivo studies using clinically relevant MM models demonstrate that single-agent CB-5083 inhibits tumor growth and combines well with MM standard of care agents. Our preclinical data demonstrate the efficacy of CB-5083 in several MM disease models and provide the rationale for clinical evaluation as monotherapy and in combination in MM.
from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2wIAXJv
Sudden sensorineural hearing loss in children and adolescents: Clinical characteristics and age-related prognosis
Source:Auris Nasus Larynx
Author(s): Jin Youp Kim, Jae Joon Han, Woong Sang Sunwoo, Ja-Won Koo, Seung-Ha Oh, Min-Hyun Park, Young Ho Kim
ObjectiveAlthough many studies have investigated sudden sensorineural hearing loss (SSNHL) in adults, there were few studies on SSNHL in the pediatric population; especially research on treatment and prognosis of pediatric SSNHL was limited. The aim of this study was to evaluate clinical characteristics, treatment outcomes and prognostic factors in children and adolescents with SSNHL.MethodsA retrospective review of medical records of 67 pediatric patients (67 ears) who had diagnosed with SSNHL at our hospitals was performed to analyze patients' clinical manifestations and audiograms. All patients were treated with high-dose systemic prednisolone (1mg/kg), and 17 of them underwent intratympanic steroid injection therapy. Audiological evaluation was carried out before and after treatment, and hearing recovery was defined as complete recovery and partial recovery according to Siegel's criteria. Patients were divided into two groups: childhood group (ages between 4 and 12 years old) and adolescence group (age>12years), and clinical characteristics and treatment outcomes were investigated. In addition, patients were divided into two groups according to degree of hearing recovery, and evaluation was made regarding possible prognostic factors.ResultsThe recovery rate in total 67 patients was 55.2%. The recovery rate of the childhood group was significantly lower than that of the adolescence group (p=0.038). While the presence of vertigo did not significantly correlate with prognosis (p=0.219), the presence of tinnitus was significantly associated with hearing recovery (p=0.005). Audiological assessment revealed that a low initial hearing threshold, high speech discrimination score, and descending type of audiogram were positively associated with hearing recovery (p=0.002, p=0.003, and p=0.029, respectively).ConclusionThe childhood group had worse treatment outcomes than the adolescence group. High initial hearing threshold and absence of tinnitus were poor prognostic factors of hearing recovery. Active treatment is required for patients with these poor prognostic factors and childhood patients with SSNHL.
from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2f5y0Jz
One-day low-intensity combined arm-leg (Cruiser) ergometer exercise intervention: cardiorespiratory strain and gross mechanical efficiency in one-legged and two-legged exercise.
from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2eME8tw
The Study of Calcium, Phosphonium, Magnesium, and Ferrum Concentration in Serum of Patients With Primary Trigeminal Neuralgia: Erratum
Research and Clinical Application of Three-Dimensional Location of Amygdaloid Body
from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2j56ssk
The Current Challenge for Plastic and Reconstructive Surgery in China, the Biggest Developing Country
Intracranial Enterogenous Cysts Close to the Brainstem Treated Through the Nerve Endoscope
from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2eHZS6f
Global Medical Cooperation With the East and West: Achieve Excellence in Craniofacial Surgery
Three-Dimensional Radiologic Study on Index Measurement of Endonasal Endoscopic Optic Nerve Decompression
from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2j49tcr
The Excellence of Graduate Medical Education in China: the New Door to Open for the Future of Young Surgeons
Eyelid and Periorbital Surgery, Second Edition, edited by Mark A. Codner and Clinton D. McCord, Jr Boca Raton, FL: CRC Press, 2016
Global Craniofacial Care
Comprehensive Treatment of Primary Orbital Arteriovenous Malformation
from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2xcsIXm
Meet Dr Kilner at the Hunterian Museum
Relative Location of Fundus Meatus Acustici Interni Via Porus Acusticus Internus in Facial Nerve Decompression
from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2xbZhF9